“Complement-ary” Therapies for Age-Related Macular Degeneration

“Complement-ary” Therapies for Age-Related Macular Degeneration

Bibliographic Details
Main Authors:	Jonathan B. Lin, MD, PhD, Rajendra S. Apte, MD, PhD
Format:	Article
Language:	English
Published:	Elsevier 2022-06-01
Series:	Ophthalmology Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666914522000446

Similar Items

Systemic Complement Activation Profiles in Nonexudative Age-Related Macular Degeneration
by: Jonathan B. Lin, MD, PhD, et al.
Published: (2022-06-01)

Age-Related Maculopathy Susceptibility 2 and Complement Factor H Polymorphism and Intraocular Complement Activation in Neovascular Age-Related Macular Degeneration
by: Yutaka Kato, MD, et al.
Published: (2022-06-01)

Neuroprotection for Age-Related Macular Degeneration
by: Jonathan B. Lin, MD, PhD, et al.
Published: (2022-12-01)

Relationships between Lipid-Related Metabolites and Age-Related Macular Degeneration Vary with Complement Genotype
by: Ralene Zi Hui Sim, MD, et al.
Published: (2022-12-01)

Systemic Dyslipidemia in Age-related Macular Degeneration
by: Brandon Li, et al.
Published: (2024-01-01)

Incidence and Clinical Practice of Exudative Age-related Macular Degeneration
by: Ai Kido, MD, et al.
Published: (2022-06-01)

Genetic Risk in Families with Age-Related Macular Degeneration
by: Anita de Breuk, MD, et al.
Published: (2021-12-01)

Rare Dysfunctional Complement Factor I Genetic Variants and Progression to Advanced Age-Related Macular Degeneration
by: Johanna M. Seddon, MD, et al.
Published: (2023-06-01)

Cell-specific Systemic Immune Signatures Associated with Treatment Burden in Neovascular Age-related Macular Degeneration
by: Joseph B. Lin, BS, et al.
Published: (2024-03-01)

Serum Cholesterol Efflux Capacity in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy
by: Yasuo Yanagi, MD, PhD, et al.
Published: (2022-06-01)

Evaluating a Causal Relationship between Complement Factor I Protein Level and Advanced Age-Related Macular Degeneration Using Mendelian Randomization
by: Amy V. Jones, PhD, et al.
Published: (2022-06-01)

Local Complement Inhibition for Geographic Atrophy in Age-Related Macular Degeneration: Prospects, Challenges, and Unanswered Questions
by: Tiarnan D.L. Keenan, BM BCh, PhD
Published: (2021-12-01)

Histology of Type 3 Macular Neovascularization and Microvascular Anomalies in Treated Age-Related Macular Degeneration
by: Andreas Berlin, MD, MS, et al.
Published: (2023-09-01)

Macular and Plasma Xanthophylls Are Higher in Age-related Macular Degeneration than in Normal Aging
by: Gerald McGwin, Jr., PhD, et al.
Published: (2023-06-01)

The complement system and age-related macular degeneration.
by: Sivaprasad, S, et al.
Published: (2006)

Plasma Metabolites Associated with OCT Features of Age-Related Macular Degeneration
by: Ines Lains, MD, PhD, et al.
Published: (2024-01-01)

Genomic-Metabolomic Associations Support the Role of LIPC and Glycerophospholipids in Age-Related Macular Degeneration
by: Ines Lains, MD, PhD, et al.
Published: (2021-03-01)

Geographic Atrophy in Age-Related Macular Degeneration
by: Tiarnan D.L. Keenan, BM BCh, PhD
Published: (2023-09-01)

Population Pharmacokinetics of Pegcetacoplan in Patients with Geographic Atrophy or Neovascular Age-related Macular Degeneration
by: Ryan L. Crass, PharmD, et al.
Published: (2025-03-01)

VEGF Inhibition Associates With Decreased Risk of Mortality in Patients With Neovascular Age-related Macular Degeneration
by: Benjamin Sommer Thinggaard, MD, et al.
Published: (2024-05-01)

Incidence and Prevalence of Neovascular Age-Related Macular Degeneration in France between 2008 and 2018
by: Catherine P. Creuzot-Garcher, MD, PhD, et al.
Published: (2022-03-01)

Systemic complement activation in age-related macular degeneration.
by: Scholl, H, et al.
Published: (2008)

Oxidative stress in the light-exposed retina and its implication in age-related macular degeneration
by: Yoko Ozawa, M.D., Ph.D.
Published: (2020-10-01)

Could Infectious Agents Play a Role in the Onset of Age-related Macular Degeneration? A Scoping Review
by: Petra P. Larsen, MD, PhD, et al.
Published: (2025-03-01)

Ultrahigh Resolution OCT Markers of Normal Aging and Early Age-related Macular Degeneration
by: Siyu Chen, PhD, et al.
Published: (2023-09-01)

A Clinical and Preclinical Assessment of Clinical Trials for Dry Age-Related Macular Degeneration
by: Muhammad Abidi, BS, et al.
Published: (2022-12-01)

Machine Learning to Predict Faricimab Treatment Outcome in Neovascular Age-Related Macular Degeneration
by: Yusuke Kikuchi, PhD, et al.
Published: (2024-03-01)

Role of Complement in the Onset of Age-Related Macular Degeneration
by: Niloofar Piri, et al.
Published: (2023-05-01)

Systemic complement activation in age-related macular degeneration.
by: Hendrik P N Scholl, et al.
Published: (2008-07-01)

Machine Learning to Predict Response to Ranibizumab in Neovascular Age-Related Macular Degeneration
by: Andreas Maunz, PhD, et al.
Published: (2023-12-01)

Phase I Study of Tivozanib Eye Drops in Healthy Volunteers and Patients with Neovascular Age-Related Macular Degeneration
by: Fumi Gomi, MD, PhD, et al.
Published: (2024-11-01)

Deep Learning Approaches for Detecting of Nascent Geographic Atrophy in Age-Related Macular Degeneration
by: Heming Yao, PhD, et al.
Published: (2024-05-01)

Longitudinal Evaluation of Visual Function Impairments in Early and Intermediate Age-Related Macular Degeneration Patients
by: Eleonora M. Lad, MD, PhD, et al.
Published: (2022-09-01)

Correction: Systemic Complement Activation in Age-Related Macular Degeneration
Published: (2008-01-01)

Correction: Systemic Complement Activation in Age-Related Macular Degeneration
Published: (2008-01-01)

Correction: Systemic Complement Activation in Age-Related Macular Degeneration.
by: Hendrik P. N. Scholl, et al.
Published: (2008-01-01)

Correction: Systemic Complement Activation in Age-Related Macular Degeneration.
by: Hendrik P. N. Scholl, et al.
Published: (2008-01-01)

Genetic Association between MMP9 and Choroidal Neovascularization in Age-Related Macular Degeneration
by: Elliott H. Sohn, MD, et al.
Published: (2021-03-01)

Deep-Learning–Aided Diagnosis of Diabetic Retinopathy, Age-Related Macular Degeneration, and Glaucoma Based on Structural and Angiographic OCT
by: Pengxiao Zang, MS, et al.
Published: (2023-03-01)

Rationale and Design of VOYAGER: Long-term Outcomes of Faricimab and Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Clinical Practice
by: Robyn Guymer, MBBS, PhD, et al.
Published: (2024-05-01)